- Home
- CVRX vs KELYA Comparison
CVRX vs KELYA Comparison
Compare CVRX & KELYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVRX
- KELYA
- Stock Information
- Founded
- CVRX 2000
- KELYA 1946
- Country
- CVRX United States
- KELYA United States
- Employees
- CVRX N/A
- KELYA N/A
- Industry
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- KELYA Professional Services
- Sector
- CVRX Health Care
- KELYA Consumer Discretionary
- Exchange
- CVRX Nasdaq
- KELYA Nasdaq
- Market Cap
- CVRX 419.8M
- KELYA 493.3M
- IPO Year
- CVRX 2021
- KELYA N/A
- Fundamental
- Price
- CVRX $13.85
- KELYA $13.87
- Analyst Decision
- CVRX Strong Buy
- KELYA Buy
- Analyst Count
- CVRX 7
- KELYA 1
- Target Price
- CVRX $17.83
- KELYA $25.00
- AVG Volume (30 Days)
- CVRX 219.8K
- KELYA 339.5K
- Earning Date
- CVRX 02-04-2025
- KELYA 02-13-2025
- Dividend Yield
- CVRX N/A
- KELYA 2.16%
- EPS Growth
- CVRX N/A
- KELYA N/A
- EPS
- CVRX N/A
- KELYA N/A
- Revenue
- CVRX $51,292,000.00
- KELYA $4,331,800,000.00
- Revenue This Year
- CVRX $27.21
- KELYA $10.12
- Revenue Next Year
- CVRX $25.87
- KELYA $3.38
- P/E Ratio
- CVRX N/A
- KELYA N/A
- Revenue Growth
- CVRX 30.53
- KELYA N/A
- 52 Week Low
- CVRX $6.40
- KELYA $12.68
- 52 Week High
- CVRX $22.50
- KELYA $25.27
- Technical
- Relative Strength Index (RSI)
- CVRX 39.53
- KELYA 50.44
- Support Level
- CVRX $14.07
- KELYA $13.11
- Resistance Level
- CVRX $15.42
- KELYA $15.11
- Average True Range (ATR)
- CVRX 0.88
- KELYA 0.51
- MACD
- CVRX -0.23
- KELYA 0.02
- Stochastic Oscillator
- CVRX 13.84
- KELYA 41.23
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
About KELYA Kelly Services Inc.
Kelly Services Inc is a provider of workforce solutions and consulting and staffing services. The company's operations are divided into five business segments namely Professional & Industrial, Science, Engineering & Technology, Education, Outsourcing & Consulting, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.